Cranford, NJ, United States of America

John W Clader

USPTO Granted Patents = 59 

 

Average Co-Inventor Count = 4.8

ph-index = 17

Forward Citations = 946(Granted Patents)

Forward Citations (Not Self Cited) = 867(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Millton, VT (US) (2013)
  • Cranford, NJ (US) (1990 - 2014)
  • Milton, VT (US) (2011 - 2016)

Company Filing History:


Years Active: 1990-2016

Loading Chart...
Loading Chart...
59 patents (USPTO):

Title: The Inventive Journey of John W Clader

Introduction:

John W Clader, a prolific inventor based in Cranford, NJ, has made significant contributions in the field of pharmaceuticals with a remarkable portfolio of 59 patents. His innovative spirit and dedication to improving healthcare have led to groundbreaking inventions that are shaping the future of medicine.

Latest Patents:

Among his latest patents is the development of bridged and fused antidiabetic compounds. These compounds serve as agonists of the G-protein coupled receptor 40 (GPR40), playing a vital role in regulating insulin levels in mammals. The compounds hold promise in the prevention and treatment of Type 2 diabetes mellitus and related conditions such as insulin resistance, obesity, and lipid disorders. Additionally, John W Clader has pioneered gamma secretase modulators, novel compounds that modulate gamma secretase activity and show potential in treating Alzheimer's Disease.

Career Highlights:

Throughout his illustrious career, John W Clader has worked with esteemed pharmaceutical companies such as Schering Corporation and Merck Sharp & Dohme Corporation. His expertise and innovative mindset have led to the development of groundbreaking pharmaceutical compounds that have the potential to revolutionize the healthcare industry.

Collaborations:

Collaboration plays a crucial role in the world of innovation, and John W Clader has had the privilege of working alongside talented individuals like Duane A Burnett and Hubert B Josien. Together, they have synergized their skills and knowledge to drive forward groundbreaking research and development in the field of pharmaceuticals.

Conclusion:

In conclusion, John W Clader stands as a trailblazing inventor whose dedication to innovation and healthcare has resulted in a remarkable portfolio of patents. His groundbreaking work in developing antidiabetic compounds and gamma secretase modulators highlights his commitment to advancing medicine and improving the lives of individuals worldwide. John W Clader's contributions will continue to inspire future generations of inventors and propel the healthcare industry towards new frontiers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…